Santiago Arroyo was appointed as a Non-Executive Director, and his career history includes work at Pfizer, Bristol Myers Squibb, Eisai, and Schwarz Pharma.
1 report, 1 independent
Updated Aug 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Santiago Arroyo was appointed as a Non-Executive Director, and his career history includes work at Pfizer, Bristol Myers Squibb, Eisai, and Schwarz Pharma.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Bristol-Myers Squibb
American pharmaceutical company
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Eisai
Japanese pharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireMaxion Therapeutics Strengthens Board with Appointment of Dr. Santiago Arroyo as a Non-Executive Director Cambridge, UK, 27 August 2025 – Maxion Therapeutics (“Maxion”), a biotechnology company devel